BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Prognosis
179 results:

  • 1. Single-cell data revealed exhaustion of characteristic NK cell subpopulations and T cell subpopulations in hepatocellular carcinoma.
    Cui Z; Li H; Liu C; Wang J; Chen C; Hu S; Zhao X; Li G
    Aging (Albany NY); 2024 Apr; 16(7):6550-6565. PubMed ID: 38604154
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. IL-22 signaling promotes sorafenib resistance in hepatocellular carcinoma via stat3/CD155 signaling axis.
    Chen J; Sun S; Li H; Cai X; Wan C
    Front Immunol; 2024; 15():1373321. PubMed ID: 38596684
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Exosomal lncRNA HEIH, an essential communicator for hepatocellular carcinoma cells and macrophage M2 polarization through the miR-98-5p/stat3 axis.
    Ai JH; Wen YZ; Dai SJ; Zhang LD; Huang ZJ; Shi J
    J Biochem Mol Toxicol; 2024 Apr; 38(4):e23686. PubMed ID: 38549433
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Deciphering the Mechanism of Siwu Decoction Inhibiting liver Metastasis by Integrating Network Pharmacology and In Vivo Experimental Validation.
    Chu X; Xie F; Hou C; Zhang X; Wang S; Xie H; An C; Li Y; Zhao L; Xue P; Zhu S
    Integr Cancer Ther; 2024; 23():15347354241236205. PubMed ID: 38462929
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Interferon-α induces differentiation of cancer stem cells and immunosuppression in hepatocellular carcinoma by upregulating CXCL8 secretion.
    Ma YT; Zheng L; Zhao CW; Zhang Y; Xu XW; Wang XY; Niu GP; Man ZS; Gu F; Chen YQ
    Cytokine; 2024 May; 177():156555. PubMed ID: 38387232
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21.
    Sui Y; Liu Q; Xu C; Ganesan K; Ye Z; Li Y; Wu J; Du B; Gao F; Song C; Chen J
    Cell Death Dis; 2024 Jan; 15(1):67. PubMed ID: 38238320
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Circ_MAPK9 promotes stat3 and LDHA expression by silencing miR-642b-3p and affects the progression of hepatocellular carcinoma.
    Wang K; Lu Q; Luo Y; Yu G; Wang Z; Lin J; Tan Z; Lao Y; Liu S; Yang H
    Biol Direct; 2024 Jan; 19(1):4. PubMed ID: 38163874
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing EGFR mRNA and pstat3 activation.
    Nulali J; Zhang K; Long M; Wan Y; Liu Y; Zhang Q; Yang L; Hao J; Yang L; Song H
    Int J Biol Sci; 2024; 20(1):331-346. PubMed ID: 38164181
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. stat3 palmitoylation initiates a positive feedback loop that promotes the malignancy of hepatocellular carcinoma cells in mice.
    Jiang Y; Xu Y; Zhu C; Xu G; Xu L; Rao Z; Zhou L; Jiang P; Malik S; Fang J; Lin H; Zhang M
    Sci Signal; 2023 Dec; 16(814):eadd2282. PubMed ID: 38051779
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. SCGN and stat3 expressions are associated with the prognosis of ccRCC.
    Lai C; Gong J; Tang J; Liu Q; Zhang M; Lai M; Zhang D; Teng X
    Pathol Res Pract; 2023 Dec; 252():154940. PubMed ID: 37977033
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression.
    Wu R; Liu W; Yang Q; Zhang J; Hou P; Xiong J; Wu L; Li E
    Sci Rep; 2023 Oct; 13(1):16998. PubMed ID: 37813900
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Tex10 interacts with stat3 to regulate hepatocellular carcinoma growth and metastasis.
    Xiang X; Kuang W; Yu C; Li Y; Su Q; Tian Y; Li J
    Mol Carcinog; 2023 Dec; 62(12):1974-1989. PubMed ID: 37792308
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. PIK3R6 Promotes Angiogenesis in Hepatocellular carcinoma by Activating stat3 Signaling Pathway.
    Du Y; Zhao W; Han H; Ren L; Ding M; Wang Y
    Altern Ther Health Med; 2023 Nov; 29(8):704-709. PubMed ID: 37708538
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. α5-nAChR/stat3/CD47 axis contributed to nicotine-related lung adenocarcinoma progression and immune escape.
    Kang G; Jiao Y; Pan P; Fan H; Li Q; Li X; Li J; Wang Y; Jia Y; Wang J; Sun H; Ma X
    Carcinogenesis; 2023 Dec; 44(10-11):773-784. PubMed ID: 37681453
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/stat3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma.
    Wu J; Xu X; Wu S; Shi W; Zhang G; Cao Y; Wang Z; Wu J; Jiang C
    Cancer Med; 2023 Sep; 12(17):18078-18097. PubMed ID: 37563971
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A potential tumor marker: Chaperonin containing TCP‑1 controls the development of malignant tumors (Review).
    Zheng L; Chen X; Zhang L; Qin N; An J; Zhu J; Jin H; Tuo B
    Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37539774
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. SSNA1 Promotes Hepatocellular Carcinoma Metastasis
    Wu LW; Hu X
    Anticancer Res; 2023 Aug; 43(8):3479-3486. PubMed ID: 37500134
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78.
    Gu Z; Wang L; Dong Q; Xu K; Ye J; Shao X; Yang S; Lu C; Chang C; Hou Y; Zhai Y; Wang X; He F; Sun A
    Proc Natl Acad Sci U S A; 2023 Jul; 120(29):e2215744120. PubMed ID: 37428911
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte-tumor cell crosstalk, local immunosuppression and tumor progression.
    Wu L; Yan J; Bai Y; Chen F; Zou X; Xu J; Huang A; Hou L; Zhong Y; Jing Z; Yu Q; Zhou X; Jiang Z; Wang C; Cheng M; Ji Y; Hou Y; Luo R; Li Q; Wu L; Cheng J; Wang P; Guo D; Huang W; Lei J; Liu S; Yan Y; Chen Y; Liao S; Li Y; Sun H; Yao N; Zhang X; Zhang S; Chen X; Yu Y; Li Y; Liu F; Wang Z; Zhou S; Yang H; Yang S; Xu X; Liu L; Gao Q; Tang Z; Wang X; Wang J; Fan J; Liu S; Yang X; Chen A; Zhou J
    Cell Res; 2023 Aug; 33(8):585-603. PubMed ID: 37337030
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. LncRNA HClnc1 facilitates hepatocellular carcinoma progression by regulating PKM2 signaling and indicates poor survival outcome after hepatectomy.
    Zhu Q; Lei Z; Xu C; Zhang Z; Yu Z; Cheng Z; Xiao P; Li S; Yu W; Zhou J
    Cancer Med; 2023 Jul; 12(13):14526-14544. PubMed ID: 37212467
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.